Trevi Therapeutics (TRVI) Invested Capital (2019 - 2023)

Trevi Therapeutics' Invested Capital history runs 3 years deep, the most recent figure standing at $153000.0 for Q4 2023.

• In Q4 2023, Invested Capital fell 97.81% year-over-year to $153000.0; the TTM figure through Sep 2024 stood at $153000.0 (down 98.94% YoY), while the FY2023 annual figure was $153000.0, down 97.81% from the prior year.
• Invested Capital for Q4 2023 stood at $153000.0, down from $7.5 million in the prior quarter.
• The five-year high for Invested Capital was $7.5 million in Q1 2023, with the low at $153000.0 in Q4 2023.
• The 3-year median for Invested Capital is $6.4 million (2021), against an average of $4.8 million.
• The sharpest annual moves came in 2022 and 2023: Invested Capital jumped 1100.69% in 2022, then plunged 97.81% in 2023.
• Trevi Therapeutics' Invested Capital stood at $5.8 million in 2021, then advanced by 20.01% to $7.0 million in 2022, then slumped by 97.81% to $153000.0 in 2023.
• Business Quant data shows TRVI's Invested Capital at $153000.0 in Q4 2023, $7.5 million in Q1 2023, and $7.0 million in Q4 2022.